Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03419182 · ClinicalTrials.gov registry record · NA

RCT Determining Best Treatment for Geriatric Acetabular Fractures

A NA study, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT03419182 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 53 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03419182, a NA study, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

There is debate over the best management for acetabular (hip) fractures that occur within the geriatric population. Geriatric patients, 60 years or older, are at greater risk for operative complications because they tend to have poorer bone quality, complicated fractures, and multiple health problems. Physicians currently have no guidelines as to the best surgical management for these particular fractures, because there is little data on the long-term outcomes of these injuries. The use of internal fixation (a nail or plate) is a standard method for repairing these injuries, however when the injuries are complicated it is predicted to have a poorer outcome than performing internal fixation along with total hip arthroplasty (joint reconstruction). Given the significant problems that result from hip fractures in this population, our study is designed to determine the best method for treatment of acetabular fractures and to clarify the criteria for treatment with guidelines assisting the physician in selecting the appropriate treatment.

Interventions

  • PROCEDURE Open Reduction internal Fixation
  • PROCEDURE Open Reduction Internal Fixation with Total Hip Arthroscopy

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2011-04-13
Est. Completion 2020-04-01
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT03419182

The ClinicalTrials.gov registry entry for NCT03419182 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Open Reduction internal Fixation is the first listed.

NCT03419182 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03419182 about?

NCT03419182 is a clinical study titled "RCT Determining Best Treatment for Geriatric Acetabular Fractures". There is debate over the best management for acetabular (hip) fractures that occur within the geriatric population. Geriatric patients, 60 years or older, are at greater risk for operative complications because they tend to have poorer bone quality, complicated fractures, and multiple health problem...

What is the current status of trial NCT03419182?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2011-04-13. Estimated completion is 2020-04-01.

What interventions are being tested in trial NCT03419182?

The interventions under investigation include: Open Reduction internal Fixation (PROCEDURE), Open Reduction Internal Fixation with Total Hip Arthroscopy (PROCEDURE).

Who is sponsoring clinical trial NCT03419182?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.